April 26, 2019 — Hologic Inc. announced global commercial availability of the Trident HD specimen radiography system. The next-generation solution delivers enhanced image quality, improved workflow and instant sample verification during breast-conserving surgeries and stereotactic breast biopsies.1
The Trident products use amorphous selenium direct capture imaging – the same detector technology used in Hologic’s 3Dimensions mammography system – to generate crisp, clear, high-resolution images. The new Trident HD system — which recently received U.S. Food and Drug Administration (FDA) clearance, a CE Mark in Europe and also launched in Canada – features a bigger detector that allows for complete imaging of larger breast surgical specimens, along with a wide range of surgical and biopsy samples.2
The system eliminates the need for clinicians to transport specimens for imaging. It also features an ergonomic design that is 37 percent smaller than the original Trident system, making it easy to maneuver in a crowded operating or procedure room. Prior mammography or biopsy images can be displayed on the same Trident HD high-resolution monitor to speed comparison and analysis, resulting in reduced procedure time and improved workflow.1 Additionally, an intuitive touchscreen interface and wireless integration supports advanced image sharing and seamless transfer of patient records to the facility’s picture archiving and communication system (PACS).
For more information: www.hologic.com
References
1. Wilson A. Trident 2.0 QUAL Qualitative Findings. Explore and identify the ideal breast biopsy verification system from the OR. Kadence International. July 2016.
2. Compared to original Trident system, which is not available in Europe
July 25, 2024 
